CYTOKINE PROFILE OF RAT BLOOD SERUM DURING EXPERIMENTAL BRONCHOPULMONARY INFLAMMATION AND IMMUNOMODULATOR ADMINISTRATION

E V Mokrenko; P D Shabanov

Medical academic journal ›› 2019, Vol. 19 ›› Issue (1S) :217 -219.

Articles

oration

CYTOKINE PROFILE OF RAT BLOOD SERUM DURING EXPERIMENTAL BRONCHOPULMONARY INFLAMMATION AND IMMUNOMODULATOR ADMINISTRATION

Author information +

History +

Abstract

Experimental bronchopneumonia was modeled by administering turpentine to the trachea under ether anesthesia. After the operation, the solution of one of the studied immunomodulators was intraperitoneally administered to the animals for 5 days (1 time/day): polyoxidonium - 0.75 mg/kg, trekrezan 25 mg/kg or metaprot 25 mg/kg. After decapitation, the interleukin profile was determined in the blood using commercial kits (Merk). Inflammation decreased blood concentrations of both proinflammatory factors (IL-1β, IL-2, IL-12, INF-γ and chemokine MCP-1), and anti-inflammatory (IL-4, IL-10) cytokines. At the same time, the levels of TNFα and IL-6, as well as the anti-inflammatory cytokine IL-13, increased. The introduction of immunomodulators, polyoxidonium, trekrezan or metaprot substantially normalized the level of pro- (IL-1β, IL-2, IL-12 (p7), chemokine MCP-1, INFα) and anti-inflammatory cytokines (IL-4, IL-10). The anti-inflammatory effect of drugs is associated with the normalization of cytokine metabolism.

Keywords

bronchopneumonia / cytokines / immunomodulators / polyoxidonium / trekrezan / metaprot

Cite this article

Download citation ▾

E V Mokrenko, P D Shabanov. CYTOKINE PROFILE OF RAT BLOOD SERUM DURING EXPERIMENTAL BRONCHOPULMONARY INFLAMMATION AND IMMUNOMODULATOR ADMINISTRATION. Medical academic journal, 2019, 19(1S): 217-219 DOI:

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Berezhnaya NM. Cytokine regulation in pathology: rapid development and unavoidable questions. Cytokines and inflammation. 2007;2(6):26-34. (In Russ.)

[2]	Zarubina IV, Mokrenko EV, Bolekhan AV, Shabanov PD. Comparative anti-inflammatory and ergotropic activity of the metaprot, trekrezan and polyoxidonium and their combinations in experimental bronchopulmonary inflammation in rats. Med. Acad. J. 2016;16(3):48-50. (In Russ.)

[3]	Ostanin AA, Leplina OYu, Shevela EYa, et al. Evaluation of the cytokine profile in patients with severe sepsis by flow-flurometry (Bio-Plex-analysis). Cytokines and inflammation. 2004;1(3):20-27. (In Russ.)

[4]	Simbirtsev AS. Cytokines: a new system of defense reactions of the body. Cytokines and inflammation. 2004;1(2):16-22. (In Russ.)

[5]	Shabanov PD, Zarubina IV, Mokrenko EV. Pharmacology of trekrezan - a new immunomodulator and adaptogen. Obz. po klin. farmakol. i lek. terapii. 2014;12(2):12-27. (In Russ.)